The term “FemTech” (short for female technology), coined in 2016 by Ida Tin, refers to consumer-centric technologies designed to improve the health and lives of those with female reproductive organs. These innovations span mobile apps, wearables, internet-connected medical devices, materials science innovations, at-home diagnostics, virtual clinics, digital communities, and more. FemTech addresses menstrual health and menopause, fertility (e.g., fertility tracking, contraception, abortion, pregnancy and pregnancy loss, and infertility), maternal and newborn health (including breastfeeding), pelvic and sexual health, and other conditions affecting women and those assigned female at birth disproportionately or differently (e.g., osteoporosis, mental health, cardiovascular disease). According to Grand View Research's 2025 analysis, the FemTech market was valued at approximately $39 billion in 2024 and is projected to reach $97 billion by 2030, reflecting rapid growth driven by increasing digital health adoption, technological innovation, and venture capital investment.
Editorial: Contraception special issue on the emergence of "FemTech" within the sexual and reproductive health landscape
